A new perspective on COPD exacerbations: Monitoring impact by measuring physical, psychological and social resilience

European Respiratory Journal

Volumn 47, Issue 4, 2016, Pages 1024-1027

  Spruit, Martijn A ^a   Franssen, Frits M E ^a   Rutten, Erica P A ^a   Wopereis, Suzan ^b   Wouters, Emiel F M ^a   Vanfleteren, Lowie E G W ^a  

^a Ciro   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY TRACT AGENT; BIOLOGICAL MARKER;

ACUTE RESPIRATORY FAILURE; ANXIETY; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COPING BEHAVIOR; COUGHING; DEPRESSION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSPNEA; EMOTIONALITY; GUILT; HUMAN; IRRITABILITY; MENTAL STRESS; METABOLIC DISORDER; PARENT COUNSELING; PATHOPHYSIOLOGY; PATIENT COUNSELING; PATIENT MONITORING; PHYSICAL STRESS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; SELF CARE; SOCIAL STRESS; SPUTUM; SYMPTOM; SYSTEMIC DISEASE; VIRAL RESPIRATORY TRACT INFECTION; LUNG; METABOLISM; METHODOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONOLOGY;

BIOMARKERS; DISEASE PROGRESSION; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; RESEARCH DESIGN; RESILIENCE, PSYCHOLOGICAL;

EID: 84964022232     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01645-2015     Document Type: Review

References (34)

1. Huber M, Knottnerus JA, Green L, et al. How should we define health? BMJ 2011; 343: d4163.
2. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117: Suppl. 2, 398S-401S.
3. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006; 61: 284-289.
4. Markoulaki D, Kostikas K, Papatheodorou G, et al. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med 2011; 22: 103-107.
5. Pavasini R, d'Ascenzo F, Campo G, et al. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Cardiol 2015; 191: 187-193.
6. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006; 173: 1114-1121.
7. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138.
8. Kessler R, Stahl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest 2006; 130: 133-142.
9. Bendixen HJ, Waehrens EE, Wilcke JT, et al. Self-reported quality of ADL task performance among patients with COPD exacerbations. Scand J Occup Ther 2014; 21: 313-320.
10. Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-67.
11. Papaioannou AI, Tsikrika S, Bartziokas K, et al. Collateral damage: depressive symptoms in the partners of COPD patients. Lung 2014; 192: 519-524.
12. Teixeira PJ, Porto L, Kristensen CH, et al. Post-traumatic stress symptoms and exacerbations in COPD patients. COPD 2015; 12: 90-95.
13. van Ommen B, van der Greef J, Ordovas JM, et al. Phenotypic flexibility as key factor in the human nutrition and health relationship. Genes Nutr 2014; 9: 423.
14. Donaldson GC, Law M, Kowlessar B, et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192: 943-950.
15. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1608-1613.
16. van den Berge M, Hop WC, van der Molen T, et al. Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease. Respir Res 2012; 13: 44.
17. Agusti AG, Villaverde JM, Togores B, et al. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1999; 14: 523-528.
18. Høiseth AD, Neukamm A, Hagve TA, et al. The clinical value of serial measurement of high-sensitivity cardiac troponin T in acute exacerbations of chronic obstructive pulmonary disease. Open Heart 2014; 1: e000001.
19. FitzGerald JM, Poureslami I. The need for humanomics in the era of genomics and the challenge of chronic disease management. Chest 2014; 146: 10-12.
20. Lundman B, Aléx L, Jonsén E, et al. Inner strength-A theoretical analysis of salutogenic concepts. Int J Nurs Stud 2010; 47: 251-260.
21. Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014; 3: CD002990.
22. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13-e64.
23. Mercken EM, Hageman GJ, Schols AM, et al. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 994-1001.
24. Cooper CB. Desensitization to dyspnea in COPD with specificity for exercise training mode. Int J Chron Obstruct Pulmon Dis 2009; 4: 33-43.
25. Vestbo J, Lange P. Prevention of COPD exacerbations: medications and other controversies. ERJ Open Res 2015; 1: 00011-2015.
26. Trappenburg JC, Troosters T, Spruit MA, et al. Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005; 86: 1788-1792.
27. Sewell L, Singh SJ, Williams JE, et al. Can individualized rehabilitation improve functional independence in elderly patients with COPD? Chest 2005; 128: 1194-1200.
28. Vincent E, Sewell L, Wagg K, et al. Measuring a change in self-efficacy following pulmonary rehabilitation: an evaluation of the PRAISE tool. Chest 2011; 140: 1534-1539.
29. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial. Lancet 2000; 355: 362-368.
30. Puhan MA, Gimeno-Santos E, Scharplatz M, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011: CD005305.
31. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 2008; 31: 869-873.
32. Stroeve JH, van Wietmarschen H, Kremer BH, et al. Phenotypic flexibility as a measure of health: The optimal nutritional stress response test. Genes Nutr 2015; 10: 459.
33. Kardinaal AF, van Erk MJ, Dutman AE, et al. Quantifying phenotypic flexibility as the response to a high-fat challenge test in different states of metabolic health. FASEB J 2015; 29: 4600-4613.
34. Geelen TH, Gaajetaan GR, Wouters EF, et al. The host immune response contributes to Haemophilus influenzae virulence. Respir Med 2014; 108: 144-152.